FDA Inspection 1096105 — Mark Noar, MD
The FDA completed an inspection of Mark Noar, MD on June 21, 2019 in Towson, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 21, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Towson, MD (United States)
Additional Details
Clinical Investigator (CI)